Choose language
< Return to main menu
Choose language
About Us
Services & Solutions
News
Resource
Contact
Career
Quality
successful US FDA inspections
2013-2021
successful EU EMA inspections
2019-2022
successful China NMPA inspections
2015-2022
successful Japan EMA inspection
2019-2022
successful South Korea MFDS inspections
2022
successful SwissMedic inspections
2018-2022
client audits
every year
country approvals for branded drugs
2013-2021
CMC submission packages written to support global IND and NDA filings since 2019
2019
CDMO to support a new drug launch in China via ONE integrated CMC platform including both drug substance and drug product
2015-2020
